CH2YYZZ
Tomographic (Tomo) Nuclear Medicine Imaging Skin, Subcutaneous Tissue and Breast to None with None, Other Radionuclide Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | C Nuclear Medicine |
| Body System | H Skin, Subcutaneous Tissue and Breast |
| Operation | 2 Tomographic (Tomo) Nuclear Medicine Imaging |
| Body Part | Y Skin, Subcutaneous Tissue and Breast |
| Approach | Y Other Radionuclide |
| Device | Z None |
| Qualifier | Z None |
Operation Definition
Introduction of radioactive materials into the body for three dimensional display of images developed from the capture of radioactive emissions
Procedure Overview
This family covers nuclear medicine scans that create three-dimensional images of the skin, subcutaneous tissue, or breast after a small amount of radioactive tracer is introduced into the body. The tracer collects in the tissue of interest, and a rotating camera captures its emissions from many angles so a computer can reconstruct cross-sectional and volumetric images, similar in concept to a CT scan but built from radioactivity rather than X-rays. The most common clinical use is lymphoscintigraphy to map the sentinel lymph node before breast cancer surgery, letting the surgeon remove only the nodes most likely to contain spreading cancer cells rather than a larger, more invasive node dissection.
Because the tomographic technique resolves depth and layering, it is chosen over a flat, single-plane scan when the surgical team needs to know not just whether a node lit up but exactly where it sits relative to skin landmarks and deeper structures. Patients typically receive the tracer by injection near the tumor site hours before imaging, and the scan itself is painless, though some may find lying still for the acquisition tedious.
Anatomy & Axis Detail
Skin, Subcutaneous Tissue and Breast
The general Skin, Subcutaneous Tissue and Breast value for tomographic imaging covers cross-sectional nuclear medicine studies of cutaneous or subcutaneous sites outside the breast, most often advanced sentinel lymph node mapping for melanoma or other skin malignancies where planar imaging alone does not adequately resolve a node's depth or its relationship to adjacent structures. Reconstructing sectional images from multiple projections allows clearer separation of superficial skin-related uptake from deeper structures, which can be important in anatomically complex regions such as the head, neck, or trunk. This code is used when the imaged structure is skin or subcutaneous tissue rather than breast tissue and no more specific body part value applies to the region studied.
Radionuclide: Other Radionuclide
Other Radionuclide is used when a nuclear medicine study employs a radioactive tracer that does not correspond to one of the specifically named isotope values in this axis, such as an uncommon or newer radiopharmaceutical. It functions as a catch-all so the procedure can still be coded precisely by section and root operation even when the exact tracer lacks its own dedicated code value.
Coding & Documentation
A coder should confirm the operative or radiology report explicitly documents a three-dimensional or SPECT-style acquisition rather than a single static image set, since planar and tomographic studies carry different root operation values even when the same tracer and body area are involved. The physiological system value for breast versus generalized skin/subcutaneous tissue also needs to match the anatomy actually imaged, not just the underlying diagnosis being worked up. A frequent error is coding a combined SPECT/CT lymphoscintigraphy study using only the nuclear medicine tables while ignoring documentation that a separate CT component was fused in, which may need its own code depending on payer and facility conventions. Another recurring mix-up is selecting the qualifier for the radionuclide or radiopharmaceutical class without verifying it against the actual agent named in the report.